Seeking Alpha

AVI BioPharma (AVII -15.4%) tanks after it says the U.S. Department of Defense told the company...

AVI BioPharma (AVII -15.4%) tanks after it says the U.S. Department of Defense told the company its proposal for the full clinical development of its influenza drug candidate, AVI-7100, didn't qualify for a contract award.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|